REPORTS

Let’s Pullulate and Expand Your Business

Global Prostate Cancer Therapeutic Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Oct 27, 2019  |  155 PAGES  |  REPORT CODE: CMM225831
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Prostate Cancer Therapeutic is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 12.8% during the forecast period. The research provides insights for the global Prostate Cancer Therapeutic market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Prostate Cancer Therapeutic industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Prostate Cancer Therapeutic Market Segmentations:

By Players:

  • F. Hoffmann-La Roche Ltd. (Switzerland)

  • Progenics Pharmaceuticals, Inc. (USA)

  • Abbott Laboratories (USA)

  • Pfizer Inc. (USA)

  • Amgen Inc. (USA)

  • Novartis AG (Switzerland)

  • Immunomedics, Inc. (USA)

  • Paladin Labs Inc. (Canada)

  • EUSA Pharma, (USA) Inc. (USA)

  • Bristol-Myers Squibb Company (USA)

  • ALZA Corporation (USA)

  • Dendreon Corporation (USA)

  • Takeda Pharmaceutical Company Limited (Japan)

  • Medimmune, LLC (USA)

  • OSI Pharmaceuticals, Inc. (USA)

  • Genentech Inc. (USA)

  • Indevus Pharmaceuticals Inc. (USA)

  • Cell Genesys Inc. (USA)

  • Spectrum Pharmaceuticals, Inc. (USA)

  • AstraZeneca PLC (UK)

  • GlaxoSmithKline Plc (UK)

  • Sanofi-Aventis SA (France)

By Types:

  • Type 1

  • Type 2

  • Type 3

By End-User:

  • End-User 1

  • End-User 2

  • End-User 3

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prostate Cancer Therapeutic Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Prostate Cancer Therapeutic Market Share by Types

    • 1.3.2 Global Prostate Cancer Therapeutic Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.3 Global Prostate Cancer Therapeutic Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.4 Global Prostate Cancer Therapeutic Market Size and Growth Rate of Type 3 from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Prostate Cancer Therapeutic Market Share by End-Users

    • 1.4.2 Global Prostate Cancer Therapeutic Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.3 Global Prostate Cancer Therapeutic Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.4 Global Prostate Cancer Therapeutic Market Size and Growth Rate of End-User 3 from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Prostate Cancer Therapeutic Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Prostate Cancer Therapeutic Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Prostate Cancer Therapeutic by Major Types

    • 3.4.1 Market Size and Growth Rate of Type 1

    • 3.4.2 Market Size and Growth Rate of Type 2

    • 3.4.3 Market Size and Growth Rate of Type 3

4 Segmentation of Prostate Cancer Therapeutic Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Prostate Cancer Therapeutic by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Prostate Cancer Therapeutic for End-User 1

    • 4.4.2 Market Size and Growth Rate of Prostate Cancer Therapeutic for End-User 2

    • 4.4.3 Market Size and Growth Rate of Prostate Cancer Therapeutic for End-User 3

5 Market Analysis by Major Regions

  • 5.1 Global Prostate Cancer Therapeutic Production Analysis by Major Regions

  • 5.2 Global Prostate Cancer Therapeutic Consumption Analysis by Major Regions

  • 5.3 Global Prostate Cancer Therapeutic Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Prostate Cancer Therapeutic Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Prostate Cancer Therapeutic Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Prostate Cancer Therapeutic Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Prostate Cancer Therapeutic Production, Import, Consumption and Export Analysis

6 Product Commodity of Prostate Cancer Therapeutic Market in Major Countries

  • 6.1 Top 5 Export Countries in Prostate Cancer Therapeutic market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Prostate Cancer Therapeutic market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Prostate Cancer Therapeutic market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Prostate Cancer Therapeutic market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Prostate Cancer Therapeutic market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Prostate Cancer Therapeutic market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Prostate Cancer Therapeutic Landscape Analysis

  • 7.1 North America Prostate Cancer Therapeutic Landscape Analysis by Major Types

  • 7.2 North America Prostate Cancer Therapeutic Landscape Analysis by Major End-Users

  • 7.3 North America Prostate Cancer Therapeutic Landscape Analysis by Major Countries

    • 7.3.1 United States Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 7.3.2 Canada Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 7.3.3 Mexico Prostate Cancer Therapeutic Market Volume and Growth Rate

8 Europe Prostate Cancer Therapeutic Landscape Analysis

  • 8.1 Europe Prostate Cancer Therapeutic Landscape Analysis by Major Types

  • 8.2 Europe Prostate Cancer Therapeutic Landscape Analysis by Major End-Users

  • 8.3 Europe Prostate Cancer Therapeutic Landscape Analysis by Major Countries

    • 8.3.1 Germany Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 8.3.2 UK Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 8.3.3 France Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 8.3.4 Italy Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 8.3.6 Spain Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 8.3.7 Belgium Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 8.3.8 Poland Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 8.3.9 Russia Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 8.3.10 Turkey Prostate Cancer Therapeutic Market Volume and Growth Rate

9 Asia Pacific Prostate Cancer Therapeutic Landscape Analysis

  • 9.1 Asia Pacific Prostate Cancer Therapeutic Landscape Analysis by Major Types

  • 9.2 Asia Pacific Prostate Cancer Therapeutic Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Prostate Cancer Therapeutic Landscape Analysis by Major Countries

    • 9.3.1 China Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 9.3.2 Japan Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 9.3.4 India Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 9.3.6 South Korea Prostate Cancer Therapeutic Market Volume and Growth Rate

10 Latin America, Middle East & Africa Prostate Cancer Therapeutic Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Prostate Cancer Therapeutic Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Prostate Cancer Therapeutic Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Prostate Cancer Therapeutic Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 10.3.2 Brazil Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 10.3.3 Nigeria Prostate Cancer Therapeutic Market Volume and Growth Rate

    • 10.3.4 South Africa Prostate Cancer Therapeutic Market Volume and Growth Rate 

    • 10.3.5 Argentina Prostate Cancer Therapeutic Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 F. Hoffmann-La Roche Ltd. (Switzerland)

    • 11.1.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Progenics Pharmaceuticals, Inc. (USA)

    • 11.2.1 Progenics Pharmaceuticals, Inc. (USA) Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Abbott Laboratories (USA)

    • 11.3.1 Abbott Laboratories (USA) Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Pfizer Inc. (USA)

    • 11.4.1 Pfizer Inc. (USA) Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Amgen Inc. (USA)

    • 11.5.1 Amgen Inc. (USA) Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Novartis AG (Switzerland)

    • 11.6.1 Novartis AG (Switzerland) Company Profile and Development Status

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Immunomedics, Inc. (USA)

    • 11.7.1 Immunomedics, Inc. (USA) Company Profile and Development Status

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Paladin Labs Inc. (Canada)

    • 11.8.1 Paladin Labs Inc. (Canada) Company Profile and Development Status

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 EUSA Pharma, (USA) Inc. (USA)

    • 11.9.1 EUSA Pharma, (USA) Inc. (USA) Company Profile and Development Status

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Bristol-Myers Squibb Company (USA)

    • 11.10.1 Bristol-Myers Squibb Company (USA) Company Profile and Development Status

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 ALZA Corporation (USA)

    • 11.11.1 ALZA Corporation (USA) Company Profile and Development Status

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Dendreon Corporation (USA)

    • 11.12.1 Dendreon Corporation (USA) Company Profile and Development Status

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 Takeda Pharmaceutical Company Limited (Japan)

    • 11.13.1 Takeda Pharmaceutical Company Limited (Japan) Company Profile and Development Status

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Medimmune, LLC (USA)

    • 11.14.1 Medimmune, LLC (USA) Company Profile and Development Status

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 OSI Pharmaceuticals, Inc. (USA)

    • 11.15.1 OSI Pharmaceuticals, Inc. (USA) Company Profile and Development Status

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 Genentech Inc. (USA)

    • 11.16.1 Genentech Inc. (USA) Company Profile and Development Status

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

  • 11.17 Indevus Pharmaceuticals Inc. (USA)

    • 11.17.1 Indevus Pharmaceuticals Inc. (USA) Company Profile and Development Status

    • 11.17.2 Market Performance

    • 11.17.3 Product and Service Introduction

  • 11.18 Cell Genesys Inc. (USA)

    • 11.18.1 Cell Genesys Inc. (USA) Company Profile and Development Status

    • 11.18.2 Market Performance

    • 11.18.3 Product and Service Introduction

  • 11.19 Spectrum Pharmaceuticals, Inc. (USA)

    • 11.19.1 Spectrum Pharmaceuticals, Inc. (USA) Company Profile and Development Status

    • 11.19.2 Market Performance

    • 11.19.3 Product and Service Introduction

  • 11.20 AstraZeneca PLC (UK)

    • 11.20.1 AstraZeneca PLC (UK) Company Profile and Development Status

    • 11.20.2 Market Performance

    • 11.20.3 Product and Service Introduction

  • 11.21 GlaxoSmithKline Plc (UK)

    • 11.21.1 GlaxoSmithKline Plc (UK) Company Profile and Development Status

    • 11.21.2 Market Performance

    • 11.21.3 Product and Service Introduction

  • 11.22 Sanofi-Aventis SA (France)

    • 11.22.1 Sanofi-Aventis SA (France) Company Profile and Development Status

    • 11.22.2 Market Performance

    • 11.22.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 93 Figures and 139 Tables)

  • Figure Product Picture

  • Figure Global Prostate Cancer Therapeutic Market Size and Growth Rate of Type 1 from 2014 to 2026

  • Figure Global Prostate Cancer Therapeutic Market Size and Growth Rate of Type 2 from 2014 to 2026

  • Figure Global Prostate Cancer Therapeutic Market Size and Growth Rate of Type 3 from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Prostate Cancer Therapeutic Market Size and Growth Rate of End-User 1 from 2014 to 2026

  • Figure Global Prostate Cancer Therapeutic Market Size and Growth Rate of End-User 2 from 2014 to 2026

  • Figure Global Prostate Cancer Therapeutic Market Size and Growth Rate of End-User 3 from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Prostate Cancer Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Prostate Cancer Therapeutic Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Prostate Cancer Therapeutic

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Prostate Cancer Therapeutic by Different Types from 2014 to 2026

  • Table Consumption Share of Prostate Cancer Therapeutic by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Type 1

  • Figure Market Size and Growth Rate of Type 2

  • Figure Market Size and Growth Rate of Type 3

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Prostate Cancer Therapeutic by Different End-Users from 2014 to 2026

  • Table Consumption Share of Prostate Cancer Therapeutic by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of End-User 1

  • Figure Market Size and Growth Rate of End-User 2

  • Figure Market Size and Growth Rate of End-User 3

  • Table Global Prostate Cancer Therapeutic Production by Major Regions

  • Table Global Prostate Cancer Therapeutic Production Share by Major Regions

  • Figure Global Prostate Cancer Therapeutic Production Share by Major Regions in 2014

  • Figure Global Prostate Cancer Therapeutic Production Share by Major Regions in 2018

  • Figure Global Prostate Cancer Therapeutic Production Share by Major Regions in 2026

  • Table Global Prostate Cancer Therapeutic Consumption by Major Regions

  • Table Global Prostate Cancer Therapeutic Consumption Share by Major Regions

  • Figure Global Prostate Cancer Therapeutic Consumption Share by Major Regions in 2014

  • Figure Global Prostate Cancer Therapeutic Consumption Share by Major Regions in 2018

  • Figure Global Prostate Cancer Therapeutic Consumption Share by Major Regions in 2026

  • Table North America Prostate Cancer Therapeutic Production, Import, Consumption and Export Analysis

  • Table Europe Prostate Cancer Therapeutic Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Prostate Cancer Therapeutic Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Prostate Cancer Therapeutic Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Prostate Cancer Therapeutic market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Prostate Cancer Therapeutic market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Prostate Cancer Therapeutic market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Prostate Cancer Therapeutic market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Prostate Cancer Therapeutic Consumption by Types from 2014 to 2026

  • Table North America Prostate Cancer Therapeutic Consumption Share by Types from 2014 to 2026

  • Figure North America Prostate Cancer Therapeutic Consumption Share by Types in 2014

  • Figure North America Prostate Cancer Therapeutic Consumption Share by Types in 2018

  • Figure North America Prostate Cancer Therapeutic Consumption Share by Types in 2026

  • Table North America Prostate Cancer Therapeutic Consumption by End-Users from 2014 to 2026

  • Table North America Prostate Cancer Therapeutic Consumption Share by End-Users from 2014 to 2026

  • Figure North America Prostate Cancer Therapeutic Consumption Share by End-Users in 2014

  • Figure North America Prostate Cancer Therapeutic Consumption Share by End-Users in 2018

  • Figure North America Prostate Cancer Therapeutic Consumption Share by End-Users in 2026

  • Table North America Prostate Cancer Therapeutic Consumption by Major Countries from 2014 to 2026

  • Table North America Prostate Cancer Therapeutic Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Prostate Cancer Therapeutic Consumption Share by Major Countries in 2014

  • Figure North America Prostate Cancer Therapeutic Consumption Share by Major Countries in 2018

  • Figure North America Prostate Cancer Therapeutic Consumption Share by Major Countries in 2026

  • Figure United States Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Prostate Cancer Therapeutic Consumption by Types from 2014 to 2026

  • Table Europe Prostate Cancer Therapeutic Consumption Share by Types from 2014 to 2026

  • Figure Europe Prostate Cancer Therapeutic Consumption Share by Types in 2014

  • Figure Europe Prostate Cancer Therapeutic Consumption Share by Types in 2018

  • Figure Europe Prostate Cancer Therapeutic Consumption Share by Types in 2026

  • Table Europe Prostate Cancer Therapeutic Consumption by End-Users from 2014 to 2026

  • Table Europe Prostate Cancer Therapeutic Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Prostate Cancer Therapeutic Consumption Share by End-Users in 2014

  • Figure Europe Prostate Cancer Therapeutic Consumption Share by End-Users in 2018

  • Figure Europe Prostate Cancer Therapeutic Consumption Share by End-Users in 2026

  • Table Europe Prostate Cancer Therapeutic Consumption by Major Countries from 2014 to 2026

  • Table Europe Prostate Cancer Therapeutic Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Prostate Cancer Therapeutic Consumption Share by Major Countries in 2014

  • Figure Europe Prostate Cancer Therapeutic Consumption Share by Major Countries in 2018

  • Figure Europe Prostate Cancer Therapeutic Consumption Share by Major Countries in 2026

  • Figure Germany Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure France Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Prostate Cancer Therapeutic Consumption by Types from 2014 to 2026

  • Table Asia Pacific Prostate Cancer Therapeutic Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Prostate Cancer Therapeutic Consumption Share by Types in 2014

  • Figure Asia Pacific Prostate Cancer Therapeutic Consumption Share by Types in 2018

  • Figure Asia Pacific Prostate Cancer Therapeutic Consumption Share by Types in 2026

  • Table Asia Pacific Prostate Cancer Therapeutic Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Prostate Cancer Therapeutic Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Prostate Cancer Therapeutic Consumption Share by End-Users in 2014

  • Figure Asia Pacific Prostate Cancer Therapeutic Consumption Share by End-Users in 2018

  • Figure Asia Pacific Prostate Cancer Therapeutic Consumption Share by End-Users in 2026

  • Table Asia Pacific Prostate Cancer Therapeutic Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Prostate Cancer Therapeutic Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Prostate Cancer Therapeutic Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Prostate Cancer Therapeutic Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Prostate Cancer Therapeutic Consumption Share by Major Countries in 2026

  • Figure China Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandProstate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure India Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutic Consumption Share by Major Countries in 2026

  • Figure GCC Countries Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Prostate Cancer Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of F. Hoffmann-La Roche Ltd. (Switzerland)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)

  • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)

  • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)

  • Table Product and Service Introduction of F. Hoffmann-La Roche Ltd. (Switzerland)

  • Table Company Profile and Development Status of Progenics Pharmaceuticals, Inc. (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals, Inc. (USA)

  • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals, Inc. (USA)

  • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals, Inc. (USA)

  • Table Product and Service Introduction of Progenics Pharmaceuticals, Inc. (USA)

  • Table Company Profile and Development Status of Abbott Laboratories (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories (USA)

  • Figure Sales and Growth Rate Analysis of Abbott Laboratories (USA)

  • Figure Revenue and Market Share Analysis of Abbott Laboratories (USA)

  • Table Product and Service Introduction of Abbott Laboratories (USA)

  • Table Company Profile and Development Status of Pfizer Inc. (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc. (USA)

  • Figure Sales and Growth Rate Analysis of Pfizer Inc. (USA)

  • Figure Revenue and Market Share Analysis of Pfizer Inc. (USA)

  • Table Product and Service Introduction of Pfizer Inc. (USA)

  • Table Company Profile and Development Status of Amgen Inc. (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc. (USA)

  • Figure Sales and Growth Rate Analysis of Amgen Inc. (USA)

  • Figure Revenue and Market Share Analysis of Amgen Inc. (USA)

  • Table Product and Service Introduction of Amgen Inc. (USA)

  • Table Company Profile and Development Status of Novartis AG (Switzerland)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland)

  • Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland)

  • Figure Revenue and Market Share Analysis of Novartis AG (Switzerland)

  • Table Product and Service Introduction of Novartis AG (Switzerland)

  • Table Company Profile and Development Status of Immunomedics, Inc. (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics, Inc. (USA)

  • Figure Sales and Growth Rate Analysis of Immunomedics, Inc. (USA)

  • Figure Revenue and Market Share Analysis of Immunomedics, Inc. (USA)

  • Table Product and Service Introduction of Immunomedics, Inc. (USA)

  • Table Company Profile and Development Status of Paladin Labs Inc. (Canada)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Paladin Labs Inc. (Canada)

  • Figure Sales and Growth Rate Analysis of Paladin Labs Inc. (Canada)

  • Figure Revenue and Market Share Analysis of Paladin Labs Inc. (Canada)

  • Table Product and Service Introduction of Paladin Labs Inc. (Canada)

  • Table Company Profile and Development Status of EUSA Pharma, (USA) Inc. (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EUSA Pharma, (USA) Inc. (USA)

  • Figure Sales and Growth Rate Analysis of EUSA Pharma, (USA) Inc. (USA)

  • Figure Revenue and Market Share Analysis of EUSA Pharma, (USA) Inc. (USA)

  • Table Product and Service Introduction of EUSA Pharma, (USA) Inc. (USA)

  • Table Company Profile and Development Status of Bristol-Myers Squibb Company (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company (USA)

  • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company (USA)

  • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company (USA)

  • Table Product and Service Introduction of Bristol-Myers Squibb Company (USA)

  • Table Company Profile and Development Status of ALZA Corporation (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ALZA Corporation (USA)

  • Figure Sales and Growth Rate Analysis of ALZA Corporation (USA)

  • Figure Revenue and Market Share Analysis of ALZA Corporation (USA)

  • Table Product and Service Introduction of ALZA Corporation (USA)

  • Table Company Profile and Development Status of Dendreon Corporation (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dendreon Corporation (USA)

  • Figure Sales and Growth Rate Analysis of Dendreon Corporation (USA)

  • Figure Revenue and Market Share Analysis of Dendreon Corporation (USA)

  • Table Product and Service Introduction of Dendreon Corporation (USA)

  • Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited (Japan)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited (Japan)

  • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited (Japan)

  • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited (Japan)

  • Table Product and Service Introduction of Takeda Pharmaceutical Company Limited (Japan)

  • Table Company Profile and Development Status of Medimmune, LLC (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medimmune, LLC (USA)

  • Figure Sales and Growth Rate Analysis of Medimmune, LLC (USA)

  • Figure Revenue and Market Share Analysis of Medimmune, LLC (USA)

  • Table Product and Service Introduction of Medimmune, LLC (USA)

  • Table Company Profile and Development Status of OSI Pharmaceuticals, Inc. (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OSI Pharmaceuticals, Inc. (USA)

  • Figure Sales and Growth Rate Analysis of OSI Pharmaceuticals, Inc. (USA)

  • Figure Revenue and Market Share Analysis of OSI Pharmaceuticals, Inc. (USA)

  • Table Product and Service Introduction of OSI Pharmaceuticals, Inc. (USA)

  • Table Company Profile and Development Status of Genentech Inc. (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech Inc. (USA)

  • Figure Sales and Growth Rate Analysis of Genentech Inc. (USA)

  • Figure Revenue and Market Share Analysis of Genentech Inc. (USA)

  • Table Product and Service Introduction of Genentech Inc. (USA)

  • Table Company Profile and Development Status of Indevus Pharmaceuticals Inc. (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indevus Pharmaceuticals Inc. (USA)

  • Figure Sales and Growth Rate Analysis of Indevus Pharmaceuticals Inc. (USA)

  • Figure Revenue and Market Share Analysis of Indevus Pharmaceuticals Inc. (USA)

  • Table Product and Service Introduction of Indevus Pharmaceuticals Inc. (USA)

  • Table Company Profile and Development Status of Cell Genesys Inc. (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell Genesys Inc. (USA)

  • Figure Sales and Growth Rate Analysis of Cell Genesys Inc. (USA)

  • Figure Revenue and Market Share Analysis of Cell Genesys Inc. (USA)

  • Table Product and Service Introduction of Cell Genesys Inc. (USA)

  • Table Company Profile and Development Status of Spectrum Pharmaceuticals, Inc. (USA)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharmaceuticals, Inc. (USA)

  • Figure Sales and Growth Rate Analysis of Spectrum Pharmaceuticals, Inc. (USA)

  • Figure Revenue and Market Share Analysis of Spectrum Pharmaceuticals, Inc. (USA)

  • Table Product and Service Introduction of Spectrum Pharmaceuticals, Inc. (USA)

  • Table Company Profile and Development Status of AstraZeneca PLC (UK)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC (UK)

  • Figure Sales and Growth Rate Analysis of AstraZeneca PLC (UK)

  • Figure Revenue and Market Share Analysis of AstraZeneca PLC (UK)

  • Table Product and Service Introduction of AstraZeneca PLC (UK)

  • Table Company Profile and Development Status of GlaxoSmithKline Plc (UK)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc (UK)

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc (UK)

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc (UK)

  • Table Product and Service Introduction of GlaxoSmithKline Plc (UK)

  • Table Company Profile and Development Status of Sanofi-Aventis SA (France)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis SA (France)

  • Figure Sales and Growth Rate Analysis of Sanofi-Aventis SA (France)

  • Figure Revenue and Market Share Analysis of Sanofi-Aventis SA (France)

  • Table Product and Service Introduction of Sanofi-Aventis SA (France)


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top